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Abstract
Objective: This study aimed to compare gas exchange with heliox and oxygen-
enriched air during piston-type high-frequency oscillatory ventilation (HFOV). We
hypothesized that helium gas would improve both carbon dioxide elimination and
arterial oxygenation during piston-type HFOV.
Method: Five rabbits were prepared and ventilated by piston-type HFOV with carrier
50% helium/oxygen (heliox50) or 50% oxygen/nitrogen (nitrogen50) gas mixture in a
crossover study. Changing the gas mixture from nitrogen50 to heliox50 and back
was performed five times per animal with constant ventilation parameters. Arterial
blood gas, vital function and respiratory test indices were recorded.
Results: Compared with nitrogen50, heliox50 did not change PaCO2 when stroke
volume remained constant, but significantly reduced PaCO2 after alignment of
amplitude pressure. No significant changes in PaO2 were seen despite significant
decreases in mean airway pressure with heliox50 compared with nitrogen50.
Conclusion: This study demonstrated that heliox enhances CO2 elimination and
maintains oxygenation at the same amplitude but with lower airway pressure
compared to air/O2 mix gas during piston-type HFOV.
Background
Helium is a noble gas with very low atomic weight (4 g/mol) and density (0.18 g/L).
When mixed with oxygen as heliox, the low density of helium reduces the resistance
associated with gas delivery. This increased mobility has three effects: gas more readily
reaches the alveoli, allowing greater diffusion; breathing effort is significantly reduced
with use of a less-dense gas; and carbon dioxide (CO2) is eliminated more rapidly [1-5].
High-frequency oscillatory ventilation (HFOV) offers a tempting advantage in main-
taining oxygenation using higher mean airway pressure with minimal risk of complica-
tions. HFOV has been used in a variety of clinical situations, including neonatal
respiratory distress syndrome, congenital diaphragmatic hernia, meconium aspiration
syndrome, and air leak syndrome. Heliox has been reported as beneficial with various
forms of nonconventional ventilation, including HFOV, high-frequency jet ventilation
(HFJV), and high-frequency percussive ventilation. Winters et al. described a case series
of 5 pediatric patients who showed marked improvements in ventilation with the use of
heliox during HFOV [6]. Gupta et al. reported combined use of heliox and HFJV to
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enhance CO2 elimination in a 5-month-old infant with acute respiratory failure,
gas-trapping, hypercarbia, respiratory acidosis, and air leak syndrome [7]. Stucki et al.
reported successful use of heliox with high-frequency percussive ventilation in a 5-year-
old boy with cystic fibrosis and severe acute respiratory failure [5]. Katz et al. used an in
vivo model of acute lung injury and found that high-frequency membrane-type oscillator
ventilation with heliox improved oxygenation and CO2 elimination. A subsequent study
by the same authors using the same animal model and ventilator showed that the
improvements seen in the first study were related to larger tidal volume (Vt) delivery by
the oscillator with heliox [3,4]. However, significant differences appear to exist between
the effects of different types of oscillator [8-11]. The effects of heliox on gas exchange
and oxygenation during piston-driven HFOV in animals or humans have not been stu-
died sufficiently in a prospective manner. The goal of our study was to examine the
effects of heliox on gas exchange and oxygenation in an animal model during high-
frequency piston-type oscillatory ventilation. We hypothesized that, compared with
oxygen-enriched air, heliox would improve both CO2 elimination and arterial
oxygenation.
Method
All study protocols were approved by the Institutional Animal Care and Use Commit-
tee of Nagano Children’s Hospital, Nagano, Japan.
Five Japanese white rabbits (body weight, 1.96 ± 0.02 kg) were used in our study.
Animals were premedicated by intramuscular administration of ketamine hydrochlor-
ide (10 mg/kg/dose) and xylazine (5 mg/kg/dose). The ear vein was cannulated using a
24-G peripheral angiocatheter for intravenous anesthesia and hydration. Animals were
placed in a supine position under a radiant warmer to maintain body temperature dur-
ing the entire study period, and body temperature was monitored using a rectal tem-
perature probe. Tracheotomy was performed, and a no-cuff endotracheal tube (ETT)
with an internal diameter of 3.0 mm (Portex, London, UK) was inserted to a depth of
4 cm and fixed in place. Intermittent ventilation (IMV) was initiated using a time-
cycled, pressure-limited commercial ventilator (Humming II; Metran, Saitama, Japan)
with: FiO2, 0.5; inspiration time (Ti), 0.6 s; positive end expiratory pressure, 5 cmH2O;
peak inspiratory pressure, 14 ± 1 cmH2O, sufficient to achieve a Vt of 10 ml/kg; and
respiratory rate, 20 breaths/min. Vt was measured during the experiment proper using
a low dead space, hot-wire pneumotachograph (LFM-317 Aivision Laminar Flow
Meter; Metabo, Lausanne, Switzerland). The carotid artery was then cannulated for
direct blood pressure measurement, heart rate (HR) monitoring and determination of
arterial blood gases (ABG). Anesthesia and myoparalysis were provided by continuous
intravenous infusion of ketamine hydrochloride (5 mg/kg/h) and pancuronium
(0.1 mg/kg/h). Arterial oxygen saturation was monitored continuously using a transcu-
taneous pulse oximeter (DDG2001; Nihon Kohden, Tokyo, Japan). These data were
displayed on a monitor throughout the experiments and recorded to a computer for
subsequent analysis. ABG were analyzed (I-STAT portable clinical analyzer; I-STAT,
East Windsor, NJ, USA) under the protocol, and then values were corrected to body
temperature. Animal hydration was maintained by infusion of 0.9% sterile NaCl from
the beginning of anesthesia at 20 ml/kg over 30 min, and at 3 ml/kg/h throughout the
whole experiment. Animals were allowed 20 min for stabilization, and then baseline
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recordings were taken and the animal was shifted to the HFOV mode of the same
ventilator (Humming II; Metran). ABG were obtained after 10 min of ventilation with
stroke volume (SV) 16 mL, which is respirator setting determining airway amplitude
pressure (AMP), mean airway pressure (MAP) 15 cmH2O, frequency 15 Hz and FiO2
0.5. Each animal was then switched to heliox50 and ventilated for 10 min before
obtaining data. After data collection with heliox50, the animal was returned to nitro-
gen50 and data were collected. The animal was subsequently changed to heliox50 and
allowed 10 min to stabilize before data collection. Ventilator settings were held con-
stant while the gas mixture was changed. The cycle of changing the gas mixture from
nitrogen50 to heliox50 and back, with constant parameters of ventilation, was per-
formed three times per animal. Using a digital pressure sensor (AP-C40, KEYENCE,
Osaka, Japan) installed into the Y-piece of the breathing circuit, actual pressure para-
meters were measured and registered. Animals were switched to heliox50 during the
fourth cycle, and ventilated to adopt the same AMP just before nitrogen50. ABG and
monitor data were also recorded. In the fifth cycle, to ensure that AMP returned to
baseline amplitude after removal of heliox, rabbits were ventilated at SV 16 ml with
nitrogen50. Finally, ABG and vital function indices were recorded.
Statistical Analysis
Experimental data have been accumulated in a spreadsheet application (Excel 2003;
Microsoft, WA, USA). All results are expressed as means ± standard deviation. Experi-
mental data were analyzed using nonparametric statistical methods and the Wilcoxon
signed-ranks test. Values of p ≤ 0.05 were considered statistically significant.
Results
MAP, AMP, PaO2 and PaCO2 values during the experiment are summarized in Table 1.
With nitrogen50 ventilation, with a setting of SV 16 ml and frequency 15 Hz, moni-
toring values were MAP 14 ± 0.55, 13.8 ± 0.6 and 13.8 ± 0.88 cmH2O, and AMP 40.1
± 0.61, 39.8 ± 1.22 and 39.8 ± 0.61 cmH2O, respectively. The shift from nitrogen50 to
heliox50 was accompanied by significant low in MAP and AMP to maintain the same
PaO2 and PaCO2. Heliox50 thus significantly reduced PaCO2 after alignment of AMP.
Discussion
Heliox has been examined previously in healthy [2,12] and injured animals [3,4] using
membrane-type high-frequency ventilation, resulting in minimal improvements in CO2
elimination. Our crossover investigation of the use of heliox during HFOV in a rabbit
model with healthy lungs revealed significant decreases in MAP and AMP to maintain
stable oxygenation and PaCO2.
Table 1 MAP, AMP, PaO2 and PaCO2 values during the experiment, FiO2, 0.5; Frequency,
15 Hz, Values represent mean ± SD. * P < 0.05
Experimental series 1 2 3 4 5
Carried Gas Nitrogen50 Heliox50 Nitrogen50 Heliox50 Nitrogen50
SV (mL) 16 16 16 25 16
MAP (cmH2O) 14 ± 0.55 11.5 ± 0.72* 13.8 ± 0.6 11.9 ± 0.85* 13.8 ± 0.88
AMP (cmH2O) 40.1 ± 0.61 28.7 ± 0.51* 39.8 ± 1.22 38.4 ± 0.95 39.8 ± 0.61
PaO2 (mmHg) 207 ± 8.6 196 ± 15.5 210 ± 26.8 204 ± 18.4 214 ± 24.3
PaCO2 (mmHg) 43 ± 13 47 ± 14 45 ± 11 33 ± 5* 43 ± 6
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Several papers have described significant differences between using different types of
high-frequency ventilators [8-11]. Those studies examined not only different types of
high-frequency ventilation, but also different types of oscillators. Differences were iden-
tified between oscillatory pressure waveforms and the efficiency of volume delivery,
both between and within each ventilator category. Jouvet et al. observed differences in
the relationship between Vt and AMP, and found that the membrane-type ventilator
had a high volume output, and may deliver “supraphysiological” Vt [11]. Pillow et al.
[9] also used an in vitro model to show that HFO performance differs according to
ventilator properties. Ventilator-displayed amplitude and airway-opening amplitude are
closely related in piston- and membrane-type ventilators, but in the case of mem-
brane-type HFOV, airway-opening amplitude was typically 50% greater than ventilator-
displayed amplitude. Vt has been shown to decrease in both types of ventilator when
frequency increased under constant ventilator-displayed amplitude. However, compar-
ing Vt between piston- and membrane-type ventilators showed that at the same fre-
quency, Vt was significantly lower for piston-type ventilators. Conversely, Hatcher et
al. [8] reported that during piston-type HFOV, CO2 transport increased in a linear
manner with increasing frequency, while a membrane-type oscillator showed decreas-
ing CO2 transport with increasing frequency. They speculated that piston-type oscilla-
tors are able to maintain stroke volume over a range of frequencies. Mildner et al. [10]
evaluated current membrane- and piston-type devices using in vitro modeling with
heliox and room air as carrier gases. They showed that speed of CO2 transport
increased in a linear manner with increasing frequency when using air as the carrier
gas for both types of ventilator. Use of heliox was followed by significant increases in
CO2 transport, but increases depended on frequency and the device. Augmentation of
CO2 transport with heliox was greatest at 5 Hz for the piston-type device, and 15 Hz
for the membrane-type ventilator [10]. Heliox may alter gas exchange during HFOV
through a number of mechanisms. As helium is less dense than nitrogen, the frictional
forces in turbulent flows are reduced with heliox as compared with oxygen-enriched
air. For a given set of airway dimensions, turbulent flow results in a higher resistance
than laminar flow. In addition, mechanical ventilation through a narrow ETT and air-
way, particularly in pediatric and neonatal patients, may further increase the Reynolds
number and thus increase turbulent flow [13,14]. Therefore, with heliox, the calculated
Reynolds number is lower, which may change regions of turbulent flow to laminar
flow, reducing resistance and energy loss. As resistive forces and energy waste are
decreased, Vt per oscillation increases. We think that the effect of increasing Vt is
dominant. This theory has been confirmed before in a laboratory study [2]. With Vt
maintained at a constant level, no improvement in gas exchange was detected when
combining heliox with HFOV. The precise mechanisms of gas exchange during HFOV
are complex and seem to be largely unelucidated [15]. In theory, because of the lower
density, heliox may favorably alter gas exchange through the pendelluft effect, inhala-
tion/exhalation flow asymmetry, Taylor dispersion, and molecular diffusion.
Conclusion
This study demonstrated that heliox enhances CO2 elimination and maintains oxyge-
nation with the same amplitude but lower airway pressure compared to air/O2 mix gas
during piston-type HFOV.
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